>

>

Efficacy and safety of once-daily antiretroviral therapy

Boyle, B.A.

Aids Reader 12(3): 90

2002

ISSN/ISBN: 1053-0894

PMID: 11966243

Document Number: 548479

Document emailed within 1 workday

Wheat, L.J.; Farthing, C.; Cohen, C.; Pierone, G.; Lalezari, J.; Pilson, R.S.; Siemon-Hryczyk, P. 2002: Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection Antiviral Therapy 7(3): 199-209

Kupryś-Lipińska, I.; Tworek, D.; Vanderbist, F.; Bocheńska-Marciniak, M.łg.; Kuna, P. 2013: Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma Pneumonologia i Alergologia Polska 81(6): 527-536

Wolf, J.E.; Kerrouche, N.; Arsonnaud, S. 2006: Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea Cutis 77(4 Suppl): 3-11

Ndiaye, J.Louis.A.; Faye, B.; Diouf, A.M.; Kuété, T.; Cisse, M.; Seck, P.A.; Brasseur, P.; Same-Ekobo, A.; Lameyre, V.; Gaye, O. 2008: Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria Malaria Journal 7: 16

Suwangool, P.; Suttinont, C.; Bowonwatanuwong, C.; Rajanuwong, A.; Kulpradist, S.A.; Dusitnanond, V.; Chayakul, P.; Chetchotisakd, P.; Leelasupasri, S.; Aswapokee, N. 1999: Efficacy and safety of twice daily administration of cefpirome in the empiric treatment of sepsis Journal of the Medical Association of Thailand 82(7): 648-653

Katlama, C.; Ingrand, D.; Loveday, C.; Clumeck, N.; Mallolas, J.; Staszewski, S.; Johnson, M.; Hill, A.M.; Pearce, G.; McDade, H. 1996: Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. a randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group JAMA 276(2): 118-125

Beigel, Y.; Brook, G.; Eisenberg, S.; Fainaru, M.; Harats, D.; Levy, Y.; Rubinstein, A.; Skurnik, Y. 1993: Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience Israel Journal of Medical Sciences 29(5): 272-277

Elewski, B.; Ling, M.R.; Phillips, T.J. 2006: Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase IIi trial Journal of Drugs in Dermatology: Jdd 5(7): 646-650

Kulthanan, K.; Gritiyarangsan, P.; Sitakalin, C.; Charuwichitratana, S.; Korkij, W.; Aunhachoke, K.; Janjumratsang, P.; Jiamton, S.; Kuntiranont, M.; Krisadapong, J.; Gherunpong, N.; Kullavanijaya, P. 2001: Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria Journal of the Medical Association of Thailand 84(2): 153-159

Manosuthi, W.; Sungkanuparph, S.; Ruxrungtham, K.; Prasithsirikul, W.; Athichathanabadi, C.; Tantisiriwat, W.; Bowonwatanuwong, C.; Chumpathat, N.; Chaovavanich, A. 2008: Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir Journal of Acquired Immune Deficiency Syndromes 47(1): 127-129

Negredo, E.; Paredes, R.; Peraire, J.; Pedrol, E.; Côté, H.; Gel, S.; Fumoz, C.R.; Ruiz, L.; Abril, V.; Rodriguez de Castro, E.; Ochoa, C.; Martinez-Picado, J.; Montaner, J.; Rey-Joly, C.; Clotet, B. 2004: Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study Antiviral Therapy 9(6): 889-893

Yakasai, A.M.; Muhammad, H.; Babashani, M.; Jumare, J.; Abdulmumini, M.; Habib, A.G. 2011: Once-daily antiretroviral therapy among treatment-experienced Muslim patients fasting for the month of Ramadan Tropical Doctor 41(4): 233-235

Kongkanand, A.; Chodchoy, V.; Lojanapiwat, B.; Pumpaisanchai, S.; Ratana-Olarn, K.; Sae-Tang, P.; Taweemonkongsap, T. 2009: Safety and efficacy of a prolonged-release formulation of alfuzosin 10 mg once daily in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia Journal of the Medical Association of Thailand 92(7): 969-978

Eichenfield, L.F.; Lain, T.; Frankel, E.H.; Jones, T.M.; Chang-Lin, J.-E.; Berk, D.R.; Ruan, S.; Kaoukhov, A. 2016: Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults with Acne Vulgaris: Second of two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials Journal of Drugs in Dermatology: Jdd 15(8): 962-969

Kakinami, L.; de Bruyn, G.; Pronyk, P.; Mohapi, L.; Tshabangu, N.; Moshabela, M.; McIntyre, J.; Martinson, N.A. 2011: The impact of highly active antiretroviral therapy on activities of daily living in HIV-infected adults in South Africa Aids and Behavior 15(4): 823-831

Staszewski, S.; Katlama, C.; Harrer, T.; Massip, P.; Yeni, P.; Cutrell, A.; Tortell, S.M.; Harrigan, R.P.; Steel, H.; Lanier, R.E.; Pearce, G. 1998: A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects Aids 12(16): F197-F202

Moore, A.; Kempers, S.; Murakawa, G.; Weiss, J.; Tauscher, A.; Swinyer, L.; Liu, H.; Leoni, M. 2014: Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study Journal of Drugs in Dermatology: Jdd 13(1): 56-61

Fowler, J.; Jackson, M.; Moore, A.; Jarratt, M.; Jones, T.; Meadows, K.; Steinhoff, M.; Rudisill, D.; Leoni, M. 2013: Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies Journal of Drugs in Dermatology: Jdd 12(6): 650-656

Pryce, C.; Pierre, R.B.; Steel-Duncan, J.; Evans-Gilbert, T.; Palmer, P.; Moore, J.; Rodriguez, B.; Christie, C.D.C. 2008: Safety of antiretroviral drug therapy in Jamaican children with HIV/AIDS West Indian Medical Journal 57(3): 238-245

Dowshen, N.; Kuhns, L.M.; Johnson, A.; Holoyda, B.James.; Garofalo, R. 2012: Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders Journal of Medical Internet Research 14(2): E51